Literature DB >> 30982700

Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis.

Ruth Ann Marrie1, John R Walker2, Lesley A Graff2, Scott B Patten3, James M Bolton4, James J Marriott5, John D Fisk6, Carol Hitchon5, Christine Peschken5, Charles N Bernstein5.   

Abstract

OBJECTIVE: We assessed the information needs of persons with any of three immune-mediated inflammatory diseases (multiple sclerosis [MS], inflammatory bowel disease [IBD] and rheumatoid arthritis [RA]) regarding depression, as a first step toward developing patient-relevant information resources, ultimately to facilitate self-management and appropriate care. We also compared information needs across genders.
METHODS: We surveyed participants with MS, IBD and RA regarding depression-related information needs including types of treatments, effectiveness, risks, benefits, and perceived helpfulness of treatments. We compared responses between groups using multivariate regression.
RESULTS: 328 participants provided complete responses (MS: 141, IBD: 114, RA: 73). Most of the topics queried were perceived as very important, and similarly important for all groups. Women placed higher importance than men on most topics. The most popular formats for receiving information were discussion with a counselor (very preferred: 67.4%) and written information (very preferred: 65.5%); this did not differ between groups.
CONCLUSIONS: Persons affected by MS, IBD and RA are interested in receiving information about multiple topics related to depression treatment, from multiple sources. Women desire more information than men. PRACTICE IMPLICATIONS: These findings can be used to design information resources to meet information needs regarding depression in MS, IBD and RA.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Inflammatory bowel disease; Information needs; Multiple sclerosis; Rheumatoid arthritis; Survey

Mesh:

Year:  2019        PMID: 30982700     DOI: 10.1016/j.pec.2019.04.007

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  3 in total

1.  Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey.

Authors:  Philipp A Reuken; Philip C Grunert; Andreas Lügering; Niels Teich; Andreas Stallmach
Journal:  Therap Adv Gastroenterol       Date:  2020-11-11       Impact factor: 4.409

2.  Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center.

Authors:  Hiba El Masri; Samantha A Hollingworth; Mieke van Driel; Helen Benham; Treasure M McGuire
Journal:  BMC Rheumatol       Date:  2020-06-16

3.  Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.

Authors:  Esam Abualfadl; Faten Ismail; Rawhya R El Shereef; Eman Hassan; Samar Tharwat; Eman F Mohamed; Essam A Abda; Ahmed R Radwan; Rasha M Fawzy; Abdel Hafeez Moshrif; Rasha Abdel Noor; Soha Senara; Mervat I Abd Elazim; Nouran M Abaza; Hala A Raafat; Iman I El-Gazzar; Dina H El-Hammady; Nevin Hammam; Tamer A Gheita; Reem El-Mallah
Journal:  Rheumatol Int       Date:  2020-11-01       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.